Coronary Artery Disease: Generx Cardio-Chant

Have a look at www.cardiumthx.com Generx® is a one-time, non-surgical angiogenic gene therapy being developed by Cardium Therapeutics (NYSE Amex CXM). This new therapeutic approach employs human growth factor DNA to stimulate the heart's natural ability to grow additional blood vessels (angiogenesis) for patients with advanced coronary artery disease and chest pain (angina pectoris). The therapy is in clinical trials and is intended to offer an innovative non-surgical option for cardiac patients who currently undergo surgical procedures such as balloon angioplasty and stents, or "open heart" cardiac bypass graft surgery (CABG). Video by: www.TBFcreations.com Music by www.JackRyanArt.com
Cardiovascular cardiac coronary artery disease CAD heart disease angiogenesis angiogenic chest pain angina pectoris open heart surgery bypass surgery cardiac bypass graft surgery CABG angioplasty gene therapy DNA therapy Generx Cardium CXM
























